Home › Funds › POTOMAC FUND MANAGEMENT INC /ADV › ABT

POTOMAC FUND MANAGEMENT INC /ADV position in ABT

ABBOTT LABORATORIES · Health Care

POTOMAC FUND MANAGEMENT INC /ADV reported holding 19,104 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.04% of its reported portfolio and ranking #37 among its reported holdings. POTOMAC FUND MANAGEMENT INC /ADV has disclosed ABT holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)19.10K sh
Reported value held$1.89M
Portfolio Weight0.04%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How POTOMAC FUND MANAGEMENT INC /ADV's ABT position evolved

POTOMAC FUND MANAGEMENT INC /ADV first disclosed a stake in ABT in Q4 2024 at 16,399 shares (US$1.9M). The position peaked in Q3 2025 at 17,691 shares, worth US$2.4M. Across 7 filings, POTOMAC FUND MANAGEMENT INC /ADV increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,104 shares valued at US$1.9M — an increase of 2,160 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 16.40K $1.85M New
Q2 2025 17.94K $2.36M New
Q3 2025 17.69K $2.37M Reduce
Q4 2025 16.68K $2.09M Reduce
Q1 2026 15.50K $1.59M Reduce
Q2 2026 16.94K $1.54M Add
Q3 2026 19.10K $1.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has POTOMAC FUND MANAGEMENT INC /ADV held ABT?

POTOMAC FUND MANAGEMENT INC /ADV has disclosed ABT holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

What is POTOMAC FUND MANAGEMENT INC /ADV's current position in ABT?

As of Q3 2026, POTOMAC FUND MANAGEMENT INC /ADV holds 19.10K shares of ABT (ABBOTT LABORATORIES), valued at $1.89M, representing 0.04% of its reported portfolio and ranking #37.

Has POTOMAC FUND MANAGEMENT INC /ADV been buying or selling ABT?

In the latest 13F filing (Q3 2026), POTOMAC FUND MANAGEMENT INC /ADV increased its position in ABT. The position peaked in Q3 2025 at 17.69K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.